用户名/邮箱
登录密码
验证码
看不清?换一张
您好,欢迎访问! [ 登录 | 注册 ]
您的位置:首页 - 最新资讯
Centre moots unified portal for drug regulation to build trust in quality
2023-07-20 00:00:00.0     商业标准报-经济和政策     原网页

       

       The Indian drug regulatory system is set for an overhaul. The Centre is working on a digital drugs regulatory system (DRS) -- a unified online portal for all regulatory activities.

       A proposal for the same was recently shared by Drugs Controller General of India (DCGI) Rajiv Singh Raghuvanshi with all state drug controllers, pharma manufacturing associations, Customs, Bureau of Indian Standards, Indian Council of Medical Research, Department of Consumer Affairs, etc, seeking their comments and suggestions. Business Standard has seen a copy of the proposal.

       TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH. Subscribe To Insights Key stories on business-standard.com are available to premium subscribers only.Already a BS Premium subscriber? Log in NOW

       MONTHLY ?8.3/day

       ?249

       Select

       Best Offer SMART ANNUAL ?4.1/day

       ?1799?1499

       Opt for auto renewal and save Rs 300

       Select

       ANNUAL ?4.9/day

       ?1799

       Select

       What you get on Business Standard Premium?

       Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app. Pick your 5 favourite companies, get a daily email with all news updates on them. Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006. Preferential invites to Business Standard events. Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more. VIEW ALL FAQs

       Or

       Also Read

       Erring firms convicted, but it's not mission accomplished for regulators

       As Singapore hangs man, these are the nations with the harshest drug laws

       Pine Labs partners ICICI Bank to enable Digital Rupee on PoS terminals

       Pricing regulator sets mechanism to fix prices of off-patent drugs

       India working on single-window portal for drug regulation processes

       Federal Bank board to consider fundraising via issue of preference shares

       Dunzo defers employee salaries for June, July till September: Report

       Hero MotoCorp targets to achieve 30% sales via digital channels by 2030

       Tax officials visit offices of edtech startup upGrad for routine survey

       Gucci's CEO is stepping down as its French parent shakes up leadership

       


标签:经济
关键词: proposal     drug controllers     premium     system     Drugs Controller General     subscribe     Standard     portal     Business    
滚动新闻